Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.

Hope W, Stone NRH, Johnson A, McEntee L, Farrington N, Santoro-Castelazo A, Liu X, Lucaci A, Hughes M, Oliver JD, Giamberardino C, Mfinanga S, Harrison TS, Perfect JR, Bicanic T.

mBio. 2019 Dec 3;10(6). pii: e02575-19. doi: 10.1128/mBio.02575-19.

2.

Patient-Reported Outcome Measures After Multilevel Lumbar Total Disc Arthroplasty for the Treatment of Multilevel Degenerative Disc Disease.

Scott-Young M, McEntee L, Zotti M, Schram B, Furness J, Rathbone E, Hing W.

Spine (Phila Pa 1976). 2020 Jan 1;45(1):18-25. doi: 10.1097/BRS.0000000000003201.

PMID:
31425431
3.

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.

Kovanda LL, Giamberardino C, McEntee L, Toffaletti DL, Franke KS, Bartuska A, Smilnak G, de Castro GC, Ripple K, Hope WW, Perfect JR.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00546-19. doi: 10.1128/AAC.00546-19. Print 2019 Sep.

4.

Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.

McEntee L, Johnson A, Farrington N, Unsworth J, Dane A, Jain A, Cotroneo N, Critchley I, Melnick D, Parr T, Ambrose PG, Das S, Hope W.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00603-19. doi: 10.1128/AAC.00603-19. Print 2019 Aug.

5.

Combined Aorto-Iliac and Anterior Lumbar Spine Reconstruction: A Case Series.

Scott-Young M, McEntee L, Furness J, Schram B, Hing W, Grosser D, Zotti M.

Int J Spine Surg. 2018 Aug 15;12(3):328-336. doi: 10.14444/5038. eCollection 2018 Jun.

6.

Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis.

Box H, Negri C, Livermore J, Whalley S, Johnson A, McEntee L, Alastruey-Izquierdo A, Meis JF, Thornton C, Hope W.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02516-17. doi: 10.1128/AAC.02516-17. Print 2018 May.

7.

Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.

Nixon GL, McEntee L, Johnson A, Farrington N, Whalley S, Livermore J, Natal C, Washbourn G, Bibby J, Berry N, Lestner J, Truong M, Owen A, Lalloo D, Charles I, Hope W.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01909-17. doi: 10.1128/AAC.01909-17. Print 2018 Apr.

8.

Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.

Negri CE, Johnson A, McEntee L, Box H, Whalley S, Schwartz JA, Ramos-Martín V, Livermore J, Kolamunnage-Dona R, Colombo AL, Hope WW.

J Infect Dis. 2018 Mar 13;217(7):1118-1127. doi: 10.1093/infdis/jix479. Erratum in: J Infect Dis. 2018 Apr 20;:.

9.

Pharmacodynamics of teicoplanin against MRSA.

Ramos-Martín V, Johnson A, McEntee L, Farrington N, Padmore K, Cojutti P, Pea F, Neely MN, Hope WW.

J Antimicrob Chemother. 2017 Dec 1;72(12):3382-3389. doi: 10.1093/jac/dkx289.

PMID:
28962026
10.

Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease.

Hope WW, McEntee L, Livermore J, Whalley S, Johnson A, Farrington N, Kolamunnage-Dona R, Schwartz J, Kennedy A, Law D, Birch M, Rex JH.

mBio. 2017 Aug 22;8(4). pii: e01157-17. doi: 10.1128/mBio.01157-17.

11.

Concurrent Use of Lumbar Total Disc Arthroplasty and Anterior Lumbar Interbody Fusion: The Lumbar Hybrid Procedure for the Treatment of Multilevel Symptomatic Degenerative Disc Disease: A Prospective Study.

Scott-Young M, McEntee L, Schram B, Rathbone E, Hing W, Nielsen D.

Spine (Phila Pa 1976). 2018 Jan 15;43(2):E75-E81. doi: 10.1097/BRS.0000000000002263.

12.

Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.

Lestner J, McEntee L, Johnson A, Livermore J, Whalley S, Schwartz J, Perfect JR, Harrison T, Hope W.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00090-17. doi: 10.1128/AAC.00090-17. Print 2017 Jun.

13.

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase.

Oliver JD, Sibley GEM, Beckmann N, Dobb KS, Slater MJ, McEntee L, du Pré S, Livermore J, Bromley MJ, Wiederhold NP, Hope WW, Kennedy AJ, Law D, Birch M.

Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12809-12814. doi: 10.1073/pnas.1608304113. Epub 2016 Oct 25.

14.

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates.

Ramos-Martín V, Johnson A, Livermore J, McEntee L, Goodwin J, Whalley S, Docobo-Pérez F, Felton TW, Zhao W, Jacqz-Aigrain E, Sharland M, Turner MA, Hope WW.

J Antimicrob Chemother. 2016 Apr;71(4):992-1002. doi: 10.1093/jac/dkv451. Epub 2016 Jan 10.

15.

Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis.

Box H, Livermore J, Johnson A, McEntee L, Felton TW, Whalley S, Goodwin J, Hope WW.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):278-87. doi: 10.1128/AAC.01364-15. Print 2016 Jan.

16.

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.

Gregson L, Goodwin J, Johnson A, McEntee L, Moore CB, Richardson M, Hope WW, Howard SJ.

Antimicrob Agents Chemother. 2013 Nov;57(11):5778-80. doi: 10.1128/AAC.01141-13. Epub 2013 Sep 16.

17.

Profiling agrammatic spoken language: towards a government and binding framework.

McEntee LJ, Kennedy M.

Eur J Disord Commun. 1995;30(3):317-32.

PMID:
8547759
18.

Comparison of two methods for determination of white blood cell counts in macaws.

Russo EA, McEntee L, Applegate L, Baker JS.

J Am Vet Med Assoc. 1986 Nov 1;189(9):1013-6. No abstract available.

PMID:
3505917

Supplemental Content

Loading ...
Support Center